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Background & Objectives: Hepatitis E virus (HEV) is the causative agent for enteric non-A, 
non-B hepatitis. Transmission is mainly via the fecal-oral route but the possibility of an 
additional parenteric transmission has been raised. Patients undergoing chronic hemodialysis 
(HD) have an increased risk of exposure to blood transmitted agents. This study looks at the 
seroepidemiology of HEV infection in the hemodialysis patients in Jahrom. 
Methods: This descriptive cross-sectional study was carried out on all (43 subjects), 
including 29 male and 14 female, referring to hemodialsis center of Jahrom, October of 2008. 
Patients' sera were tested for anti-HEV antibody by a specific solid- phase enzyme-linked 
immunoassay (Diapro, Italy). 
Results: The overall seroprevalence of hepatitis E was 7.00% (95% CI: 8.1–10.8).  No 
significant association was found between HEV seropositivity and age, sex and duration of 
hemodialysis. 
Conclusion: Our investigation of HEV infection in the HD patients in Jahrom showed that 
the prevalence of anti-HEV was lower than the prevalence of anti-HEV in HD patients in 
other researches. 
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